These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 19580789

  • 1. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.
    Kubota-Koketsu R, Mizuta H, Oshita M, Ideno S, Yunoki M, Kuhara M, Yamamoto N, Okuno Y, Ikuta K.
    Biochem Biophys Res Commun; 2009 Sep 11; 387(1):180-5. PubMed ID: 19580789
    [Abstract] [Full Text] [Related]

  • 2. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K.
    Biochem Biophys Res Commun; 2010 Mar 19; 393(4):614-8. PubMed ID: 20152806
    [Abstract] [Full Text] [Related]

  • 3. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y, Stegalkina S, Zhang J, Boudanova E, Park A, Zhou Y, Prabakaran P, Pougatcheva S, Ustyugova IV, Vogel TU, Mundle ST, Oomen R, Delagrave S, Ross TM, Kleanthous H, Qiu H.
    J Virol; 2020 Feb 28; 94(6):. PubMed ID: 31826999
    [Abstract] [Full Text] [Related]

  • 4. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S.
    J Virol; 2014 Jul 28; 88(13):7130-44. PubMed ID: 24719430
    [Abstract] [Full Text] [Related]

  • 5. Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.
    Shibuya T, Yamashiro T, Masaike Y, Ohuchi M, Uechi G, Nishizono A.
    Microbiol Immunol; 2008 Mar 28; 52(3):162-70. PubMed ID: 18402598
    [Abstract] [Full Text] [Related]

  • 6. Human monoclonal antibodies broadly neutralizing against influenza B virus.
    Yasugi M, Kubota-Koketsu R, Yamashita A, Kawashita N, Du A, Sasaki T, Nishimura M, Misaki R, Kuhara M, Boonsathorn N, Fujiyama K, Okuno Y, Nakaya T, Ikuta K.
    PLoS Pathog; 2013 Feb 28; 9(2):e1003150. PubMed ID: 23408886
    [Abstract] [Full Text] [Related]

  • 7. Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice.
    Voutssas-Lara J, Cervantes-Torres J, Hernández M, Bobes RJ, Lamoyi E, Vázquez-Ramírez RA, Mendoza L, Reyes-Barrera KL, López-Martínez R, Alpuche-Solís ÁG, Rosales-Mendoza S, Huerta L, Fragoso G, Sciutto E.
    Mol Immunol; 2021 Jul 28; 135():398-407. PubMed ID: 34022515
    [Abstract] [Full Text] [Related]

  • 8. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
    Klimova RR, Masalova OV, Burtseva EI, Chichev EV, Lesnova EI, Oskerko TA, Mukasheva EA, Rudneva IA, Lvov DK, Kushch AA.
    Vopr Virusol; 2011 Jul 28; 56(3):15-20. PubMed ID: 21786621
    [Abstract] [Full Text] [Related]

  • 9. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N, Panthong S, Koksunan S, Chittaganpitch M, Phuygun S, Waicharoen S, Prachasupap A, Sasaki T, Kubota-Koketsu R, Yasugi M, Ono K, Arai Y, Kurosu T, Sawanpanyalert P, Ikuta K, Watanabe Y.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):865-70. PubMed ID: 25204499
    [Abstract] [Full Text] [Related]

  • 10. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.
    Vigil A, Frias-Staheli N, Carabeo T, Wittekind M.
    J Virol; 2020 Oct 27; 94(22):. PubMed ID: 32847855
    [Abstract] [Full Text] [Related]

  • 11. Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus.
    Guo CY, Tang YG, Qi ZL, Liu Y, Zhao XR, Huo XP, Li Y, Feng Q, Zhao PH, Wang X, Li Y, Wang HF, Hu J, Zhang XJ.
    Immunobiology; 2015 Aug 27; 220(8):941-6. PubMed ID: 25708705
    [Abstract] [Full Text] [Related]

  • 12. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G, Liu Y, Flyer D, Massare MJ, Zhou B, Patel N, Ellingsworth L, Lewis M, Cummings JF, Glenn G.
    Vaccine; 2017 Sep 25; 35(40):5366-5372. PubMed ID: 28844407
    [Abstract] [Full Text] [Related]

  • 13. Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza A virus broadly cross-neutralize group 1 influenza viruses.
    Pan Y, Sasaki T, Kubota-Koketsu R, Inoue Y, Yasugi M, Yamashita A, Ramadhany R, Arai Y, Du A, Boonsathorn N, Ibrahim MS, Daidoji T, Nakaya T, Ono K, Okuno Y, Ikuta K, Watanabe Y.
    Biochem Biophys Res Commun; 2014 Jul 18; 450(1):42-8. PubMed ID: 24858683
    [Abstract] [Full Text] [Related]

  • 14. The influenza virus hemagglutinin head evolves faster than the stalk domain.
    Kirkpatrick E, Qiu X, Wilson PC, Bahl J, Krammer F.
    Sci Rep; 2018 Jul 11; 8(1):10432. PubMed ID: 29992986
    [Abstract] [Full Text] [Related]

  • 15. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
    Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P.
    PLoS Pathog; 2010 Feb 26; 6(2):e1000796. PubMed ID: 20195520
    [Abstract] [Full Text] [Related]

  • 16. An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.
    Yoon A, Yi KS, Chang SY, Kim SH, Song M, Choi JA, Bourgeois M, Hossain MJ, Chen LM, Donis RO, Kim H, Lee Y, Hwang DB, Min JY, Chang SJ, Chung J.
    PLoS One; 2015 Feb 26; 10(10):e0141312. PubMed ID: 26512723
    [Abstract] [Full Text] [Related]

  • 17. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
    Yamayoshi S, Ito M, Uraki R, Sasaki T, Ikuta K, Kawaoka Y.
    J Infect; 2018 Feb 26; 76(2):177-185. PubMed ID: 29248585
    [Abstract] [Full Text] [Related]

  • 18. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.
    Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, Sokolove J, Robinson WH.
    Clin Immunol; 2014 Mar 26; 151(1):55-65. PubMed ID: 24525048
    [Abstract] [Full Text] [Related]

  • 19. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.
    Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC.
    Nature; 2008 May 29; 453(7195):667-71. PubMed ID: 18449194
    [Abstract] [Full Text] [Related]

  • 20. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.